Clinical Trials Directory

Trials / Completed

CompletedNCT05620875

The Association Between Delivered Oxygen and Cerebral Impact During the Use of Cardiopulmonary Bypass.

Status
Completed
Phase
Study type
Observational
Enrollment
106 (actual)
Sponsor
Uppsala University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Investigating the connection between delivered oxygen index and cerebral impact with COx (cerebral oximetry index) och cerebral injury markers during the routine use of cardiopulmonary bypass.

Detailed description

The research subjects are to be treated with CPB with according to local standards (perfusion index 2.4 x body surface area). While measuring impact on cerebral autoregulation with the aid of Near InfraRed Spectroscopy (NIRS) and brain injury markers in blood, research subjects depending on initial hemoglobin value, will divide into two subgroups: one with DO2I of \>280 ml/min/m2, and one with DO2I of \<280 ml/min/m2. DO2I will during CPB be calculated using the patient data monitoring system Metavision. With a correlation analysis between NIRS and MAP (mean arterial pressure) a COx (Cerebral Oxymetry Index) r-value can indicate impact on cerebral autoregulation with values \>0.3 - 0.5 during use of CPB 4. Brain injury markers (Tau, Glial Fibrillary Acidic Protein (GFAP), Neurospecific Enolase (NSE)) are collected during 5 occasions during the first 24 hours and then once per day for 4 days, as well as markers for AKI (S-Creatinine) in some extent. Registrations during the intensive care regarding delirium, stroke or other neurological impact will also be included in the study.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCerebral injury markersBlood tests at given time points perioperatively.
DIAGNOSTIC_TESTCerebral oximetry indexCerebral oximetry index measurements with the aid of Near Infrared Spectroscopy

Timeline

Start date
2023-01-02
Primary completion
2025-01-04
Completion
2025-01-04
First posted
2022-11-17
Last updated
2025-05-30

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT05620875. Inclusion in this directory is not an endorsement.